Dodson said success looks like hundreds in mid CY17, to many hundreds and possibly thousands per quarter late in CY17
This 4c may be one or two quarters too early to be hitting 1000's
Regarding Q3's sales, I reckon to be on-track Q3 needs > 500 unit sales and having on-boarded > 120 hospitals, which would be 68% and 20% growth on previous quarter (thoughts?)
AXP have generally delivered on promises, though they have been out on timing, often due to matters out of their control, this is an emotive product, not a launch you want to rush so you can hit sales figures IMO
Add to My Watchlist
What is My Watchlist?
 (20min delay)
|
|||||
|
Last
0.1¢ |
Change
0.000(0.00%) |
Mkt cap ! $6.684M | |||
| Open | High | Low | Value | Volume |
| 0.1¢ | 0.1¢ | 0.1¢ | $550 | 550K |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 11 | 17532286 | 0.1¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 0.2¢ | 59699936 | 44 |
View Market Depth
| Last trade - 09.59am 21/07/2025 (20 minute delay) ? |
| AXP (ASX) Chart |